FPF
ARMO

FNY Partners Fund’s ARMO BioSciences, Inc. Common Stock ARMO Stock Holding History

FNY Partners Fund’s Portfolio ARMO Stock Details ARMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$9K Buy
+250
New +$10.5K ﹤0.01% 274

Other funds holding ARMO

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

FNY Partners Fund's ARMO Position: Q1 2018 in Review

FNY Partners Fund opened a new position in ARMO BioSciences, Inc. Common Stock (ARMO) in Q1 2018: 250 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #274 among its holdings.

65 funds tracked by Wall St. Rank hold ARMO as of Q1 2018.

  • FNY Partners Fund held 250 shares of ARMO BioSciences, Inc. Common Stock worth $9K as of Q1 2018.
  • ARMO BioSciences, Inc. Common Stock was a new FNY Partners Fund position in Q1 2018.
  • ARMO BioSciences, Inc. Common Stock made up ﹤0.01% of FNY Partners Fund's portfolio in Q1 2018, its #274 holding.
  • 65 funds tracked by Wall St. Rank held ARMO BioSciences, Inc. Common Stock as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.